CCA - Treatment and quality of life

Research output

Research output per year 1981 2017 2018 2019 2020 2021 2022 2023 2024

• 6906 Article
• 846 Review article
• 372 Comment/Letter to the editor
• 294 Meeting Abstract
• 879 More
  • 197 Chapter
  • 184 Phd-Thesis - Research and graduation internal
  • 172 Letter
  • 111 Editorial
  • 58 Conference contribution
  • 33 Report
  • 25 Erratum/Corrigendum
  • 22 Poster
  • 21 Abstract
  • 15 Short survey
  • 12 Book
  • 7 Book/Film/Article review
  • 5 Paper
  • 5 Phd-Thesis - Research and graduation external
  • 4 Phd-Thesis - Research internal and graduation external
  • 3 Inaugural speech
  • 2 Other contribution
  • 2 Patent
  • 1 Book editing

Research output per year

Research output per year

Search results

• 2023

  Natural speech as a digital biomarker in preclinical Alzheimer’s disease: Usability and reliability of a remote burst speech assessment

  van den Berg, R. L., de Boer, C., Zwan, M. D., Robin, J., Simpson, B., Harrison, J. E., Jutten, R. J., Dubbelman, M. A., Barkhof, F., Collij, L. E., van Harten, A. C., Mank, A., Kroeze, L. A., Teunissen, C. E., van der Flier, W. M. & Sikkes, S. A. M., 17 Jul 2023.

  Research output: Contribution to conference › Poster › Academic
• 2022

  Wait time until surgery: patients' preferences (ESGO 2022)

  Aarts, J., Lok, C., van den Berg, K. & Fons, G., 28 Oct 2022.

  Research output: Contribution to conference › Poster › Academic
• 2020

  1390P Impact of adding viagenpumatucel-L to nivolumab in non-small cell lung cancer (NSCLC) patients with low levels of tumour infiltrating lymphocytes

  Bahce, I., Hashemi, SMS., Fransen, MF., Veltman, JD. & Thunnissen, FBJM., 2020, p. S883.

  Research output: Contribution to conference › Poster › Academic

• 766P - Prognostic effect of systemic immune-inflammation index (SII) in 987 patients with advanced/metastatic urinary tract carcinoma (mUTC) treated with atezolizumab in the real-world global SAUL study

  Voortman, J., 17 Sept 2020.

  Research output: Contribution to conference › Poster › Academic

• PO-0996: Early mortality in stage III NSCLC after radical non-surgical therapy following ESMO guidelines

  Ronden-Kianoush, M., de Vries, I. F. R., Bahce, I., De Haan, P. F., Tiemessen, M. A., Spoelstra, F. O. B., Van Diepen, V. D. M., Haasbeek, C. J. A., Tarasevych, S., Daniels, H. J. M. A., Dahele, M. R., Hashemi, S. M., Becker, A., Veltman, J. D., Crombag, L. M. M., Senan, S. & Verbakel, W. F. A. R., 2020, p. S531-S532.

  Research output: Contribution to conference › Poster › Academic
• 2019

  A Phase II/III trial of high-dose, intermittent sunitinib in patients with recurrent glioblastoma: The STELLAR study

  Kouwenhoven, MCM., 2019, p. AM2019-CT117.

  Research output: Contribution to conference › Poster › Academic

• Pursuit of an international language of glioma research: common data elements for the longitudinal study of adult malignant glioma

  Kouwenhoven, MCM., 2019, (Accepted/In press).

  Research output: Contribution to conference › Poster › Academic
• 2018

  NLSEV2018-P21 - EV-derived microRNA profiles from patients with classical Hodgkin Lymphoma can discriminate between active disease and complete response

  Voortman, J., 2018.

  Research output: Contribution to conference › Poster › Academic
• 2017

  2964 - Comparison of carboplatin with 5-fluorouracil (carbo-5FU) versus cisplatin as concomitant chemoradiotherapy (CRT) for locally advanced head and neck squamous cell carcinoma (LA-HNSCC)

  Voortman, J., 10 Sept 2017.

  Research output: Contribution to conference › Poster › Academic

• A phase 1/2 study of intermittent, high dose sunitinib in patients with advanced solid tumors.

  Voortman, J., 2017.

  Research output: Contribution to conference › Poster › Academic

  Open Access

• Gemcitabine resistant pancreatic cancer cells are sensitive to paclitaxel treatment

  Le Large, TYS., 2017.

  Research output: Contribution to conference › Poster › Academic

• Gemcitabine resistant pancreatic cancer cells are sensitive to taxane treatment.

  Le Large, TYS., 2017.

  Research output: Contribution to conference › Poster › Academic

• Phosphoproteome networks display consistent hyperactive kinase activity in pancreatic cancer: evidence for new therapeutic options.

  Le Large, TYS., 2017.

  Research output: Contribution to conference › Poster › Academic

• Phosphoproteome networks identify focal adhesion kinase as new drug target in combination with paclitaxel regimens.

  Le Large, TYS., 2017.

  Research output: Contribution to conference › Poster › Academic

• Rapid development of peritoneal metastases after adjuvant chemotherapy is associated with worse survival after cytoreduction and HIPEC

  Sluiter, NR., Salhi, Y., Vlek, SL. & Tuynman, JB., 2017.

  Research output: Contribution to conference › Poster › Academic
• 2016

  S471 SKELETAL MUSCLE MASS MEASUREMENTS AND ASSOCIATION WITH TREATMENT OUTCOME IN PATIENTS WITH LOCALLY ADVANCED HEAD AND NECK CANCER TREATED WITH CONCURRENT CHEMORADIOTHERAPY

  Voortman, J., 2016.

  Research output: Contribution to conference › Poster › Academic
• 2014

  A phase I study of DMOT4039A, an antibody-drug conjugate (ADC) targeting mesothelin (MSLN), in patients (pts) with unresectable pancreatic (PC) or platinum-resistant ovarian cancer (OC).

  Voortman, J., 2014.

  Research output: Contribution to conference › Poster › Academic

  Open Access
• 2011

  Array-based comparative genomic hybridization analysis to identify prognostic markers for resected pancreatic cancer.

  Voortman, J., 2011.

  Research output: Contribution to conference › Poster › Academic
• 2010

  Abstract 2995: MicroRNA expression and outcome of adjuvant chemotherapy in patients with completely resected non-small cell lung cancer: International Adjuvant Lung Cancer Trial Biologic Program (IALT-Bio)

  Voortman, J., 2010.

  Research output: Contribution to conference › Poster › Academic

  Open Access

• Abstract 3000: MicroRNA-21 as a biomarker for benefit from adjuvant therapy in resectable pancreatic adenocarcinoma

  Voortman, J., 2010.

  Research output: Contribution to conference › Poster › Academic

  Open Access

• Curriculum development for robotic assisted surgery in gynecologic oncology

  van Lonkhuijzen, L., 4 Dec 2010.

  Research output: Contribution to conference › Poster › Academic

• Palliative radiotherapy for cervical cancer in Tanzania

  van Lonkhuijzen, L. & Thomas, G., 5 Jun 2010.

  Research output: Contribution to conference › Poster › Academic